Quest LaboratoriesNSE:QUESTLAB -0.10%44 Cash Ratio is 1.06 as of Mar. 2026, which is 563% above its 10-year median of 0.16. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 8 warning signs investors should review. Among 974 Drug Manufacturers companies, Quest Laboratories ranks better than 63.35% on this metric.
Quest Laboratories has a Cash Ratio of 1.06. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Quest Laboratories's Cash Ratio or its related term are showing as below:
NSE:QUESTLAB'
s Cash Ratio Range Over the Past 10 Years
Min: 0.04 Med: 0.16 Max: 1.33
Current: 1.06
During the past 6 years, Quest Laboratories's highest Cash Ratio was 1.33. The lowest was 0.04. And the median was 0.16.
NSE:QUESTLAB's Cash Ratio is ranked better than 63.35% of 974
companies
in the Drug Manufacturers industry
Industry Median: 0.605
vs NSE:QUESTLAB: 1.06
Quest Laboratories (NSE:QUESTLAB) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Quest Laboratories Cash Ratio Related Terms
Quest Laboratories Cash Ratio Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: Cash Ratio Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories Cash Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a Cash Ratio of 1.06 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Quest Laboratories and its competitors. This is 563% above median its historical median of 0.16. Over the past decade, Quest Laboratories' Cash Ratio has ranged from 0.04 to 1.33. According to the industry distribution chart, Quest Laboratories ranks #357 out of 974 companies in the Drug Manufacturers industry, placing it in the top 36.7%.
Is Quest Laboratories' Cash Ratio too high?
Quest Laboratories' current Cash Ratio of 1.06 is 563% above median its 10-year median of 0.16. Over the past 10 years, this metric has ranged from a low of 0.04 to a high of 1.33. The Drug Manufacturers industry median Cash Ratio is 0.61. Quest Laboratories' value of 1.06 is 75.2% above this industry median. Based on the distribution chart, Quest Laboratories ranks #357 out of 974 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Cash Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #357 out of 974 companies for Cash Ratio. This puts Quest Laboratories in the upper half of its industry. The industry median Cash Ratio is 0.61. Quest Laboratories' value of 1.06 is 75.2% above this benchmark. Historically, Quest Laboratories' own Cash Ratio has ranged from 0.04 to 1.33 over the past decade. While the company's 10-year median is 0.16 vs. the industry median of 0.61, Quest Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Drug Manufacturers company?
The median Cash Ratio among Drug Manufacturers companies is 0.61, based on 974 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current Cash Ratio of 1.06 is 75.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median Cash Ratio is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current Cash Ratio is 1.06, which is 563% above median its own 10-year median of 0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Cash Ratio of 1.06. The current Cash Ratio is 1.06, which is 563% above median its 10-year median of 0.16 and 75.2% above the Drug Manufacturers industry median of 0.61. Quest Laboratories' overall GF Score™ is 44/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Cash Ratio is 1.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score
Get the complete analysis for NSE:QUESTLAB
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 
